- In October 2023, Clariant, a specialty chemicals company committed to sustainability, introduced its new range of high-performing pharmaceutical ingredient solutions aimed at advancing the development of safe and effective medications. In addition, Clariant Health Care expanded its selection of functional excipients designed to address challenges related to the delivery and bioavailability of active pharmaceutical ingredients (APIs)
- In September 2023, Roquette, a company specializing in plant-based ingredients and offering pharmaceutical and nutraceutical excipients, added three new excipient grades to its portfolio. These new grades are specifically tailored for moisture-sensitive active pharmaceutical and nutraceutical ingredients
- In June 2023, Ashland launched Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant that incorporates a glidant and lubricant. Designed to streamline development and save time, this multifunctional disintegrant enhances powder flow and lubrication in pharmaceutical manufacturing. By reducing two manufacturing steps and simplifying equipment setup, this innovative product not only improves tablet hardness but also ensures the consistent production of high-quality products in both batch and continuous manufacturing processes
- In September 2022, DFE Pharma, a prominent provider of pharmaceutical and nutraceutical excipient solutions, launched its new “Closer to the Formulator” (C2F) Center of Excellence in Hyderabad, India. The C2F aims to assist pharmaceutical companies in reducing the time from concept to finished commercial product by leveraging its expertise throughout all stages of pharmaceutical development. This initiative has allowed the company to demonstrate its progress in the industry
- In February 2022, Kerry Group Plc, a global leader in taste and nutrition, announced two significant biotechnology acquisitions that enhanced its expertise, technology portfolio, and manufacturing capabilities. The company acquired c-LEcta, a top biotechnology innovation firm specializing in precision fermentation, optimized bio-processing, and bio-transformation, along with Enmex, a well-established enzyme manufacturer in Mexico that provides various bio-process solutions for the food, beverage, and animal nutrition sectors
Frequently Asked Questions
The market is segmented based on Segmentation By Functionality (Binders And Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidents, Chelating Agents, Antifoaming Agents, and Others), Dosage Form (Solid, Semi-Solid, and Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, and Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) – Industry Trends and Forecast to 2031
.
The Global Pharmaceutical Excipients Market size was valued at USD 8.31 USD Billion in 2023.
The Global Pharmaceutical Excipients Market is projected to grow at a CAGR of 6.6% during the forecast period of 2024 to 2031.
The major players operating in the market include Kerry Group plc, DFE Pharma, Cargill ,orporated, Pfanstiehl, Colorcon, MEGGLE GmbH & Co. KG, Roquette Frères, The Lubrizol Corporation, BASF SE, Avantor , BENEO Chemie Trade-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
